Founded in 1968 and headquartered in Queensland, Australia, ECOT Group is a high-tech multinational biotechnology enterprise centered on genetic engineering and life sciences. ECOT always adheres to the concept of “caring for life, caring for health”, and has been deeply engaged in the field of animal health care for more than 50 years, focusing on the research and development of green and non-antibiotic products, production and technological innovation, and successfully developed interferon, lysozyme, and microbial enzymes, which are regarded as natural antibiotics, through the use of gene cloning technology and on a large scale. Through gene cloning technology, we have successfully developed recombinant protein products such as interferon, interleukin 2, thymic peptide and antibody protein fragments, as well as diversified functional raw materials such as lactobacillus, clostridium butyricum, bacillus coagulans, transfer factors, plant extracts and mycotoxinolytic enzymes, forming an ecological system that covers the prevention of animal diseases, immune restoration, and the whole chain of healthy breeding.

In 2003, the ECOT Group launched the industry milestone product “E-Tech Lysozyme”, which is the first time that lysozyme technology is applied to the clinical treatment of animal diseases and immune system repair, pioneering the first non-anti-animal protection technology. In order to deepen its global network, the Group focuses on the fields of “Animal Immune System Repair” and “Antibiotic-Free Healthy Breeding” through its Hong Kong subsidiary, ECOT Group (China) Investment Limited, and its proprietary brand, LOVOL, which is operated by Hangzhou Pu'ai Bio-technology Co. Ltd. and its proprietary brand LOVOL (operated by Hangzhou PUAI Biotechnology Co., Ltd.), focusing on the fields of “animal immune system repair” and “anti-resistance-free healthy farming”, providing customized solutions for China's Top 100 livestock enterprises and animal protection manufacturers, relying on animal-derived immune factors to activate the body's self-healing power, and combining the synergistic technologies of genetic engineering and natural therapies, to promote the development of a green, safe, and sustainable aquaculture industry, and to assist customers in building their differential competitiveness. The Group is committed to becoming a technology leader in the global animal healthcare industry and a practitioner of eco-health concepts by optimizing its product system through market research and experimental validation based on clinical needs.

Core Advantages

Technology gene, innovation-driven: with genetic engineering as the core technology barrier, we independently research and develop recombinant protein products and microbial preparations, and own a number of core technologies such as lysozyme, interferon, transfer factor, etc. The products have high efficiency, safety and precise targeting, which can satisfy the market demand under the trend of no-antibiotic breeding.

Full-category coverage, precise solutions: The product line covers poultry, swine, ruminants and aquatic products, providing full-cycle solutions from immune enhancement (e.g. Immunopeptide), disease control (e.g. Huperzine), intestinal health (e.g. Lactobacillus complex) to performance enhancement (e.g. EggBao) to realize the customized service of “one enterprise, one policy”.

Professional Team, Efficient Execution: Adhering to the team culture of “like-minded, self-improvement”, we build a champion team with business, management and scientific research qualities, and ensure the efficient implementation of technology research and development and marketing services with the goal-oriented and result-oriented working mode.

Industry benchmark customer endorsement: Focus on serving the domestic head livestock enterprises, products through the scale of application verification, to help customers build differentiated competitiveness, market share continues to increase.

Stringent quality, full control: from raw material selection to production process, the whole process follows international standards to ensure product stability and safety, and through clinical trials to verify the effect, to provide customers with reliable protection.

Customer demand-oriented, continuous iteration: With “solving market problems” as the origin of research and development, we dynamically meet the new demands of the breeding industry in the fields of disease prevention and control, non-antibiotic transformation, etc., through a rapid response mechanism and continuous technological upgrading.

Hangzhou ECOT® is not only an explorer of biotechnology, but also a co-builder of green farming ecology. We are committed to becoming a benchmark for innovation in the global animal protection industry and creating sustainable value with our partners by empowering health with technology and driving development with responsibility.